Finlay is a TSXV company focused on exploration for base and precious metal deposits with four properties in northern British Columbia. In addition to the SAY, the Company has two Toodoggone ...

All securities issued in connection with closing of each of the Offering and Shares for Debt Settlement will be subject to a statutory hold period of four months plus a day from the date of issuance ...

Scandium Canada Ltd. Makes Changes to its Management Team and Corporate Structure and Announces Grant of Stock Options ...

Rentokil Initial plc Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - RTO ...

MONTREAL, Nov. 28, 2024 /PRNewswire/ - CAE has been awarded on the Forbes list of the World's Top Companies for Women 2024. This prestigious award is presented in collaboration with Statista, the ...

Calgary, Alberta-- (Newsfile Corp. - November 28, 2024) - Record Resources Inc. (TSXV: REC) reports that the company is increasing the total size of its financing it is presently undertaking via a ...

Mr. Xiaohua Gu, who had served as CFO since 2016, is stepping down voluntarily to pursue new opportunities. The Company wishes to express its profound gratitude for Mr. Gu's contributions over the ...

In connection the LIFE Offering, the Company: (i) paid an aggregate of $40,944.36 and (ii) issued an aggregate of 1,364,812 non-transferrable finder's units (each, a "Finder's Unit") to eligible ...

In the three months ended September 30, 2024, operating income soared to $348,983, while normalized EBITDA climbed to $466,458 - significant increases from $110,704 and $337,815, respectively, in Q2 ...

Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline ...

The Company has appointed Camilo Cordovez Amador as Vice President of Finance for the Company. Camilo brings a wealth of experience in both the financial and mining sectors. Camilo brings over 16 ...

HUTCHMED Announces Continued Inclusion of ORPATHYS® (savolitinib) in the National Reimbursement Drug List in China at Current Terms ...